Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest over $6 billion to boost production capacity.
About Us
- 6-Toyo-Kaiji Bldg., 2-8-11, Nishi-Shimbashi, Minato-ku, Tokyo, Japan
- +81 3 6670 1726
Services
Send Us A Message
To make an inquiry, or to learn more about what we do and how we can help you or your organization, please click the link below.
© 2023 Ellinghams. All Rights Reserved
